| Application no. and date | 15154393.1 (espacenet) (Federated) (European Patent Register), 20071003 | | Patent/reg. no. and date | DK/EP 2918288, 20170816 | | Publication date | 20150916 | | Priority no. and date | US 827933 P, 20061003 | | EP pub. no. and date |
EP 2918288 20150916 | | Effective date | | | Applicant/owner | Genzyme Corporation, 450 Water Street
CAMBRIDGE, MA 02141 , US,
The General Hospital Corporation, Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114, US | | Applicant ref. no. | SAN 5382-EP-EPD | | Inventor | Streisand, James B., c/o Genzyme Corporation
500 Kendall Street
Cambridge, Massachusetts 02142, US,
Roberts, Jesse D., 21 Dustin Street
Brighton, Massachusetts 02135, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 11/00 (2006.01) , A61K 39/00 (2006.01) , A61K 45/06 (2006.01) , C07K 16/22 (2006.01) | | Title | Anvendelse af TGF-beta-antagonister til behandling af spædbørn med risiko for udvikling af bronkopulmonal dysplasi | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
